Mary Harner
About Mary Harner
Mary Harner is the Associate Director at Bristol Myers Squibb and a Group Fitness Instructor at Team85 Fitness & Wellness, with a strong background in pharmaceutical sciences and extensive experience in biophysical techniques.
Current Role at Bristol Myers Squibb
Mary Harner serves as the Associate Director at Bristol Myers Squibb. In this role, she leads a team focused on small molecule biophysics, emphasizing molecular properties and interactions studies. Her work is integral to the company's research and development efforts, particularly in the realm of drug discovery.
Experience as Senior Manager, Oncology CI
From 2021 to 2022, Mary Harner held the position of Senior Manager, Oncology CI at Bristol Myers Squibb for a year. During her tenure, she contributed to the oncology competitive intelligence team, providing valuable insights to guide strategic decision-making.
Background in Research and Academia
Mary Harner's academic and professional background is rooted in pharmaceutical sciences and biochemistry. She earned her PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill, where she was also a graduate student from 2006 to 2011. Prior to that, she completed her BS in Biochemistry at Elizabethtown College from 2002 to 2006. She also worked as a Postdoctoral Research Fellow at Vanderbilt University from 2011 to 2014.
Group Fitness Instructor Roles
In addition to her scientific career, Mary Harner is currently a Group Fitness Instructor at Team85 Fitness & Wellness. She has held similar roles at various fitness centers, including RWJ Fitness & Wellness Center - Hamilton from 2018 to 2021 and Iron Core Bootcamp in 2018 for 7 months. These positions highlight her commitment to a balanced lifestyle and community engagement outside of her primary professional focus.
Previous Positions at Bristol Myers Squibb
Mary Harner has had a progressive career at Bristol Myers Squibb with various roles. She was a Senior Research Investigator II from 2019 to 2021 in Princeton, New Jersey, a Senior Research Investigator I from 2018 to 2021, and a Research Investigator II and I from 2014 to 2018. Her extensive experience at the company showcases her expertise in biophysics, molecular interactions, and structural biology.